Investigating Potential Lawsuits involving NexPoint Capital
Are you concerned about your investment in NexPoint Capital? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Dispute Resolution claim against the brokerage firm that sold you the investment.
NexPoint Capital, Inc. is a business development company specializing in medium-sized businesses in the healthcare sector, according to Bloomberg.
According to SEC filings, NexPoint Capital filed a Form D to raise capital from investors in 2014. Investments such as these are typically sold by brokerage firms in exchange for a large up front commission. High fees can range from 7-10%, as well as additional “due diligence fees” that can range from 1-3%.
The problem with private placement investments such as NexPoint Capital is that they typically involve a high degree of risk. They are also often sold as unregistered securities which lack the same regulatory oversight as more traditional investment products like stocks or bonds.
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for improperly recommending high-risk private placements, like NexPoint Capital to investors.
Broker dealers are required to perform adequate due diligence on any investment they recommend and to ensure that all recommendations are suitable for the investor. Firms that fail to do so, may be held responsible for any losses in a FINRA arbitration claim.
If you have concerns regarding your investment in NexPoint Capital and would like to speak with a securities attorney about your options, please call The White Law Group at 888-637-5510.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visit https://whitesecuritieslaw.com.
Tags: NexPoint Capital, NexPoint Capital complaints, NexPoint Capital default, NexPoint Capital help, NexPoint Capital high commissions, NexPoint Capital information, NexPoint Capital investigation, NexPoint Capital investment, NexPoint Capital investment losses, NexPoint Capital investor relations, NexPoint Capital investors, NexPoint Capital losses, NexPoint Capital ppm, NexPoint Capital private placement, NexPoint Capital prospectus, NexPoint Capital recovery options, NexPoint Capital risk, NexPoint Capital stock information, NexPoint Capital update Last modified: March 11, 2019